Quercetin Phytosome

Quercetin Phytosome is not a new chemical but a delivery form of quercetin, the common plant flavonol ^[1]. A phytosome is a complex in which a plant compound is bound to phospholipids, typically food-grade lecithin, so that the resulting particle mixes more readily with the fats and membranes of the digestive tract ^[1]. The approach was designed to solve a long-standing problem with quercetin: in its ordinary form the molecule dissolves poorly and is absorbed only in tiny amounts after being eaten, which has frustrated efforts to obtain useful effects from oral quercetin ^[1]. By packaging quercetin with lecithin, the phytosome greatly increases its solubility and uptake ^[1].

The central claim for Quercetin Phytosome is improved bioavailability, and this was tested in a randomized crossover study in healthy volunteers ^[1]. Compared with unformulated quercetin, the phytosome produced substantially higher blood levels and greater overall exposure of quercetin, reported as an increase of roughly twenty-fold in total quercetin, without notable side effects ^[1]. Because the amount of quercetin reaching the circulation is the main barrier to its use, this large gain in absorption is the principal rationale for the product ^[1].

With a more absorbable form available, researchers examined whether quercetin's laboratory activities might translate into clinical effects. Much of this work took place during the COVID-19 pandemic, prompted by findings that quercetin can inhibit certain proteins of the SARS-CoV-2 virus and by its anti-inflammatory properties ^[2]. A pilot study in healthcare workers suggested that taking Quercetin Phytosome over several months was associated with fewer symptomatic COVID-19 infections than placebo ^[3]. A later systematic review and meta-analysis of several randomized trials found that quercetin reduced the likelihood of hospitalisation and intensive care admission in COVID-19 patients, with the authors noting that benefits were most plausible when the more bioavailable phytosome form was used, while cautioning that the trials were small and that larger studies are needed ^[2]. It is worth noting that several of these studies involved the product's manufacturer, and the overall evidence remains preliminary ^[1][3].

Quercetin Phytosome is marketed as a dietary supplement, generally in capsule or tablet form, rather than as an approved medicine ^[3]. It carries the same underlying compound as ordinary quercetin and so shares quercetin's generally favourable safety record, with the phytosome study reporting no notable adverse effects ^[1]. As with quercetin itself, no regulator has authorized it as a treatment for any disease, and it is sold under proprietary names as a branded ingredient ^[2][3].

Well tolerated; high doses can cause GI upset or headache. Quercetin can inhibit some drug-metabolizing enzymes and transporters, creating theoretical interactions with certain medications. Kidney caution is sometimes raised at very high chronic doses. Overall low risk at typical intakes.